Exelixis (EXEL) PT Lowered to $27 at RBC Capital
Tweet Send to a Friend
RBC Capital analyst Kennen MacKay lowered the price target on Exelixis (NASDAQ: EXEL) to $27.00 (from $28.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
